Home›People›Linda Tempelman
Linda Tempelman

Linda Tempelman

CEO, Cofounder and director at Persista Bio. Also an executive officer and director at HydroSpire.

ExecutiveDirectorRoles at 2 startups
Updated Nov 10, 2026·Latest SEC filing Apr 29, 2026·Suggest an edit

About Linda Tempelman

Linda Tempelman is CEO, Cofounder and director at Persista Bio.

Form D filings also name Linda Tempelman as an executive officer and director at HydroSpire.

Linda Tempelman first appears on SEC filings in 2023.

Experience

This experience comes from Linda Tempelman's profile and from SEC filings. For roles taken from filings, the years are when the filings name Linda Tempelman in the role, so the role may have started earlier or lasted longer.

Persista Bio Inc. Current
CEO, Cofounder and director
Chief Executive Officer (2023 – Present)
2023 – Present · City of Lewes, DE
Develops an implantable cell therapy system for people with Type 1 diabetes.
HydroSpire Inc. Current
Co-Founder (2022 – Present)
Director
2022 – Present · Framingham, MA
Giner, Inc. Current
Senior Consultant (1999 – Present)
Chief Scientific Officer (2017 – 2021)
1999 – Present
CytoTherapeutics
Staff Scientist
1996 – 1997
Naval Research Laboratory
Postdoc
1994 – 1996
Celanese Fibers
Staff Engineer
1985 – 1987

Key Colleagues at Startups

The people Linda Tempelman works with at each company, as listed on that company's latest Form D.

HydroSpire Inc. · Form D, May 17, 2023
PH
Peter Hemingway
CFO and director
DL
Douglas Lawrence
Executive officer and director

Sources

  1. SECPersista Bio Inc. Form D, filed Apr 29, 2026
  2. SECHydroSpire Inc. Form D, filed May 17, 2023